Associate Professor Tam Wai Leong, Deputy Executive Director of A*STAR Genome Institute of Singapore (A*STAR GIS), and ...

The approval follows a heightened regulatory focus on CAR-T cell therapy safety this year. In April, the FDA mandated boxed ...

While Monday’s trading session was a win for CERo shareholders, the stock’s year-to-date (YTD) performance paints a more complex picture. As of today, CERO is down by a staggering -98.59% YTD, which ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced members of the management team are scheduled to partic ...

The scientific program's plenary sessions cover: Novel therapies and international considerations in access and regulatory approval Economics of novel cellular therapies Transplantation and cell ...